Scientific Health Development (SHD) is a venture capital firm founded in 2006 and based in Dallas, TX. The firm invests in early-stage, innovative medical device and medtech companies at the intersection of enhanced patient outcomes, improved economics, and usability.
Deal activity increased 100% year-over-year (2 deals in the last 12 months). Their most common stage is series-a (43% of deals). Average disclosed round size is $11.0M (across 14 rounds with reported amounts).
Portfolio
12
Fund Size
—
Top Stage
Series A
Last 12 Mo
2
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Urologic | Seed | $11M | May 2026 |
 SecondWave Systems | Series A | $7M | Oct 2025 |
| SecondWave Systems | Series A | $7M | Apr 2025 |
 Koya Medical | Series B | $26M | Nov 2023 |
| LLiberate Medical | Series B | $6.2M | Jul 2023 |
| Koya Medical | Series A | $11M | Jan 2023 |
 Empirical Spine | Series B | $10M | Jun 2021 |
 Mindera Corporation | Series A | $12.6M | May 2021 |
 Procyrion | Series C | $16M | Jan 2018 |
 Channel Medsystems | Unknown | $14.1M | Jan 2017 |
 Sight Sciences | Series B | $7M | — |
 Mindera Health | Series A | $5.3M | — |
 SecondWave | Series A | $7M | — |
 Podimetrics | Series B | $13.4M | — |
Top Co-Investors
Mountain Group Partners2 shared
University of Minnesota2 shared
True Ventures2 shared
Sectoral Asset Management2 shared
OrbiMed2 shared
Longwood Fund1 shared
Third Point Ventures1 shared
Aperture Venture Partners1 shared
Asahi Kasei1 shared
Revelation Partners1 shared
Pivotal Life Sciences1 shared
The Longevity Fund1 shared
Edge Medical Ventures1 shared
Undisclosed Angel Investors1 shared
Rock Health1 shared
Polaris Partners1 shared
WndrCo1 shared
Cota Capital1 shared
Khosla Ventures1 shared
Pear VC1 shared
Last updated: 20 October 2026